Association of Neutrophil-to-Lymphocyte Ratio with Nutrition in Patients with Various Types of Malignant Tumors: A Multicenter Cross-Sectional Study

References

• Goh BK, Chok AY, Allen JC Jr. et al. Blood neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios are independent prognostic factors for surgically resected gastrointestinal stromal tumors. Surgery. 2016;159(4):1146–1156.
   PubMed Web of Science ®Google Scholar
• Goh BK, Tan DM, Chan CY, et al. Are preoperative blood neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios useful in predicting malignancy in surgically-treated mucin-producing pancreatic cystic neoplasms? J Surg Oncol. 2015;112(4):366–371. doi:10.1002/jso.23997
   PubMedGoogle Scholar
• Mantovani A, Allavena P, Sica A, Balkwill F. Cancer-related inflammation. Nature. 2008;454(7203):436–444. doi:10.1038/nature07205
   PubMed Web of Science ®Google Scholar
• Hsieh MC, Wang SH, Chuah SK, Lin YH, Lan J, Rau KM. A prognostic model using inflammation- and nutrition-based scores in patients with metastatic gastric adenocarcinoma treated with chemotherapy. Medicine. 2016;95(17):e3504. doi:10.1097/MD.0000000000003504
   PubMedGoogle Scholar
• Guthrie GJ, Charles KA, Roxburgh CS, Horgan PG, McMillan DC, Clarke SJ. The systemic inflammation-based neutrophil-lymphocyte ratio: experience in patients with cancer. Crit Rev Oncol Hematol. 2013;88(1):218–230. doi:10.1016/j.critrevonc.2013.03.010
   PubMed Web of Science ®Google Scholar
• Luo G, Guo M, Liu Z, et al. Blood neutrophil-lymphocyte ratio predicts survival in patients with advanced pancreatic cancer treated with chemotherapy. Ann Surg Oncol. 2015;22(2):670–676. doi:10.1245/s10434-014-4021-y
   PubMedGoogle Scholar
• Bhatti I, Peacock O, Lloyd G, Larvin M, Hall RI. Preoperative hematologic markers as independent predictors of prognosis in resected pancreatic ductal adenocarcinoma: neutrophil-lymphocyte versus platelet-lymphocyte ratio. Am J Surg. 2010;200(2):197–203. doi:10.1016/j.amjsurg.2009.08.041
   PubMedGoogle Scholar
• Stotz M, Gerger A, Eisner F, et al. Increased neutrophil-lymphocyte ratio is a poor prognostic factor in patients with primary operable and inoperable pancreatic cancer. Br J Cancer. 2013;109(2):416–421. doi:10.1038/bjc.2013.332
   PubMed Web of Science ®Google Scholar
• Yang JJ, Hu ZG, Shi WX, Deng T, He SQ, Yuan SG. Prognostic significance of neutrophil to lymphocyte ratio in pancreatic cancer: a meta-analysis. World J Gastroenterol. 2015;21(9):2807–2815. doi:10.3748/wjg.v21.i9.2807
   PubMed Web of Science ®Google Scholar
• Paramanathan A, Saxena A, Morris DL. A systematic review and meta-analysis on the impact of pre-operative neutrophil lymphocyte ratio on long term outcomes after curative intent resection of solid tumours. Surg Oncol. 2014;23(1):31–39. doi:10.1016/j.suronc.2013.12.001
   PubMed Web of Science ®Google Scholar
• Cohen SJ, Pinover WH, Watson JC, Meropol NJ. Pancreatic cancer. Curr Treat Options Oncol. 2000;1(5):375–386. doi:10.1007/s11864-000-0065-2
   PubMedGoogle Scholar
• Ronga I, Gallucci F, Riccardi F, Uomo G. Anorexia-cachexia syndrome in pancreatic cancer: recent advances and new pharmacological approach. Adv Med Sci. 2014;59(1):1–6. doi:10.1016/j.advms.2013.11.001
   PubMedGoogle Scholar
• Pacelli F, Bossola M, Rosa F, Tortorelli AP, Papa V, Doglietto GB. Is malnutrition still a risk factor of postoperative complications in gastric cancer surgery? Clin Nutr. 2008;27(3):398–407. doi:10.1016/j.clnu.2008.03.002
   PubMed Web of Science ®Google Scholar
• Sierzega M, Niekowal B, Kulig J, Popiela T. Nutritional status affects the rate of pancreatic fistula after distal pancreatectomy: a multivariate analysis of 132 patients. J Am Coll Surg. 2007;205(1):52–59. doi:10.1016/j.jamcollsurg.2007.02.077
   PubMed Web of Science ®Google Scholar
• Schwegler I, von Holzen A, Gutzwiller JP, Schlumpf R, Mühlebach S, Stanga Z. Nutritional risk is a clinical predictor of postoperative mortality and morbidity in surgery for colorectal cancer. Br J Surg. 2010;97(1):92–97. doi:10.1002/bjs.6805
   PubMed Web of Science ®Google Scholar
• Gao Y, Zhou S, Jiang W, Huang M, Dai X. Effects of ganopoly (a ganoderma lucidum polysaccharide extract) on the immune functions in advanced-stage cancer patients. Immunol Invest. 2003;32(3):201–215. doi:10.1081/IMM-120022979
   PubMed Web of Science ®Google Scholar
• McMillan DC. Systemic inflammation, nutritional status and survival in patients with cancer. Curr Opin Clin Nutr Metab Care. 2009;12(3):223–226. doi:10.1097/MCO.0b013e32832a7902
   PubMed Web of Science ®Google Scholar
• Deans C, Wigmore SJ. Systemic inflammation, cachexia and prognosis in patients with cancer. Curr Opin Clin Nutr Metab Care. 2005;8(3):265–269. doi:10.1097/01.mco.0000165004.93707.88
   PubMed Web of Science ®Google Scholar
• Wu J, Chen M, Liang C, Su W. Prognostic value of the pretreatment neutrophil-to-lymphocyte ratio in cervical cancer: a meta-analysis and systematic review. Oncotarget. 2017;8(8):13400–13412. doi:10.18632/oncotarget.14541
   PubMed Web of Science ®Google Scholar
• Song C, Cao J, Zhang F, et al. Nutritional risk assessment by scored patient-generated subjective global assessment associated with demographic characteristics in 23,904 common malignant tumors patients. Nutr Cancer. 2019;71(1):50–60. doi:10.1080/01635581.2019.1566478
   PubMed Web of Science ®Google Scholar
• Wang K, Karin M. Tumor-elicited inflammation and colorectal cancer. Adv Cancer Res. 2015;128:173–196.
   PubMed Web of Science ®Google Scholar
• Yu JM, Yang M, Xu HX, et al. association between serum C-reactive protein concentration and nutritional status of malignant tumor patients. Nutr Cancer. 2019;71(2):240–245. doi:10.1080/01635581.2018.1524019
   PubMed Web of Science ®Google Scholar
• Singh N, Baby D, Rajguru JP, Patil PB, Thakkannavar SS, Pujari VB. Inflammation and cancer. Ann Afr Med. 2019;18(3):121–126. doi:10.4103/aam.aam_56_18
   PubMed Web of Science ®Google Scholar
• Sacdalan DB, Lucero JA, Sacdalan DL. Prognostic utility of baseline neutrophil-to-lymphocyte ratio in patients receiving immune checkpoint inhibitors: a review and meta-analysis. Onco Targets Ther. 2018;11:955–965. doi:10.2147/OTT.S153290
   PubMed Web of Science ®Google Scholar
• Lecot P, Sarabi M, Pereira Abrantes M, et al. Neutrophil heterogeneity in cancer: from biology to therapies. Front Immunol. 2019;10:2155. doi:10.3389/fimmu.2019.02155
   PubMedGoogle Scholar
• McMillan DC. An inflammation-based prognostic score and its role in the nutrition-based management of patients with cancer. Proc Nutr Soc. 2008;67(3):257–262. doi:10.1017/S0029665108007131
   PubMed Web of Science ®Google Scholar
• Cupp MA, Cariolou M, Tzoulaki I, Aune D, Evangelou E, Berlanga-Taylor AJ. Neutrophil to lymphocyte ratio and cancer prognosis: an umbrella review of systematic reviews and meta-analyses of observational studies. BMC Med. 2020;18(1):360. doi:10.1186/s12916-020-01817-1
   PubMed Web of Science ®Google Scholar
• Templeton AJ, McNamara MG, Šeruga B, et al. Prognostic role of neutrophil-to-lymphocyte ratio in solid tumors: a systematic review and meta-analysis. J Natl Cancer Inst. 2014;106(6):dju124. doi:10.1093/jnci/dju124
   PubMedGoogle Scholar
• Song C, Wang K, Guo Z, et al. Investigation of nutritional status in Chinese patients with common cancer. Sci Sin Vitae. 2020;50(12):1437–1452. doi:10.1360/SSV-2020-0297
   Google Scholar
• Lauby-Secretan B, Scoccianti C, Loomis D, Grosse Y, Bianchini F, Straif K. Body fatness and cancer--viewpoint of the IARC working group. N Engl J Med. 2016;375(8):794–798. doi:10.1056/NEJMsr1606602
   PubMed Web of Science ®Google Scholar
• Lennon H, Sperrin M, Badrick E, Renehan AG. The obesity paradox in cancer: a review. Curr Oncol Rep. 2016;18(9):56. doi:10.1007/s11912-016-0539-4
   PubMed Web of Science ®Google Scholar
• Stienstra R, van Diepen JA, Tack CJ, et al. Inflammasome is a central player in the induction of obesity and insulin resistance. Proc Natl Acad Sci U S A. 2011;108(37):15324–15329. doi:10.1073/pnas.1100255108
   PubMed Web of Science ®Google Scholar
• Lee DH, Giovannucci EL. The obesity paradox in cancer: epidemiologic insights and perspectives. Curr Nutr Rep. 2019;8(3):175–181. doi:10.1007/s13668-019-00280-6
   PubMedGoogle Scholar
• Fonseca G, Farkas J, Dora E, von Haehling S, Lainscak M. Cancer cachexia and related metabolic dysfunction. Int J Mol Sci. 2020;21(7):2321. doi:10.3390/ijms21072321
   PubMedGoogle Scholar
• Bala C, Gheorghe-Fronea O, Pop D, et al. The association between six surrogate insulin resistance indexes and hypertension: a population-based study. Metab Syndr Relat Disord. 2019;17(6):328–333.
   PubMed Web of Science ®Google Scholar
• Dahlman I, Mejhert N, Linder K, et al. Adipose tissue pathways involved in weight loss of cancer cachexia. Br J Cancer. 2010;102(10):1541–1548. doi:10.1038/sj.bjc.6605665
   PubMed Web of Science ®Google Scholar
• Das SK, Eder S, Schauer S, et al. Adipose triglyceride lipase contributes to cancer-associated cachexia. Science. 2011;333(6039):233–238. doi:10.1126/science.1198973
   PubMed Web of Science ®Google Scholar
• Zhang C, Yang Q, Zhang Y, et al. The relationship between the ratio of triglyceride to high-density lipoprotein cholesterol and muscle loss in patients with type 2 diabetes. Chin J Diabetes Mellitus. 2020;12(09):721–725.
   Google Scholar
• Huiskamp LFJ, Chargi N, Devriese LA, May AM, Huitema ADR, de Bree R. The predictive value of low skeletal muscle mass assessed on cross-sectional imaging for anti-cancer drug toxicity: a systematic review and meta-analysis. J Clin Med. 2020;9(11):3780. doi:10.3390/jcm9113780
   PubMedGoogle Scholar
• Beaudart C, Zaaria M, Pasleau F, Reginster JY, Bruyère O, Wright JM. Health outcomes of sarcopenia: a systematic review and meta-analysis. PLoS One. 2017;12(1):e0169548. doi:10.1371/journal.pone.0169548
   PubMed Web of Science ®Google Scholar
• Ebadi M, Baracos VE, Bathe OF, Robinson LE, Mazurak VC. Loss of visceral adipose tissue precedes subcutaneous adipose tissue and associates with n-6 fatty acid content. Clin Nutr. 2016;35(6):1347–1353. doi:10.1016/j.clnu.2016.02.014
   PubMedGoogle Scholar
• Ebadi M, Martin L, Ghosh S, et al. Subcutaneous adiposity is an independent predictor of mortality in cancer patients. Br J Cancer. 2017;117(1):148–155. doi:10.1038/bjc.2017.149
   PubMed Web of Science ®Google Scholar
• Shu Y, He S, Chen XP, et al. 甘油三酯和高密度脂蛋白胆固醇与炎症的关系 [Relations between fasting serum lipids and high-sensitivity C-reactive protein level in Chengdu residents]. Zhonghua Xin Xue Guan Bing Za Zhi. 2012;40(2):125–130. Chinese. doi:10.3760/cma.j.issn.0253-3758.2012.02.010.
   PubMedGoogle Scholar